Skip to main content
. 2013 Mar 20;304(11):F1390–F1397. doi: 10.1152/ajprenal.00292.2012

Fig. 3.

Fig. 3.

Removing angiotensin II from the bath does not alter the effect of NO donors on JCl. JCl (A) and VT (B) were measured in CCDs from aldosterone-treated mice before and after the application of an NO donor (10 μM MAHMA NONOate) when angiotensin II was not present in the bath. In the absence of angiotensin II, application of MAHMA reduced JCl from 62.2 ± 5.8 to 22.2 ± 3.8 pmol·mm−1·min−1, and reduced VT from −28.4 ± 2.6 to −14.9 ± 2.9 mV, respectively.